Norovirus Specific Neutra™ Antibody Products
Product listAccelerate Your Research and Development!
Are you currently facing challenges in rapidly and accurately detecting norovirus in clinical or environmental samples, or in developing effective therapeutic or prophylactic solutions? Creative Biolabs' Norovirus Specific Antibody Products help you overcome these hurdles by enabling precise detection, supporting research into viral pathogenesis, and accelerating the development of next-generation diagnostic and therapeutic tools through high-specificity antibodies.
Contact our team to get an inquiry now!
Introduction of Norovirus
Norovirus is a highly contagious, non-enveloped RNA virus belonging to the family Caliciviridae. It is the leading cause of epidemic acute gastroenteritis worldwide, affecting millions of people annually and leading to significant morbidity and economic burden. The virus is primarily transmitted through the fecal-oral route via contaminated food, water, or surfaces, and through person-to-person contact, including exposure to aerosolized vomit. Its high infectivity and environmental stability make it a formidable public health challenge. The norovirus genome contains three open reading frames (ORFs): ORF1 encodes non-structural proteins necessary for viral replication, while ORF2 and ORF3 encode the major (VP1) and minor (VP2) capsid proteins, respectively. The VP1 protein is the major structural component of the viral capsid and is essential for host cell recognition and entry. The significant genetic and antigenic diversity of noroviruses, particularly within the GII.4 genotype, poses a challenge to vaccine development, as new variants constantly emerge, escaping existing immunity.
Fig.1 Electron microscope capture of norovirus.Distributed under Public Domain, from Wiki, without modification
Our Anti-Norovirus Antibody Products
The unique structure of norovirus, particularly its prominent VP1 capsid protein, makes it an excellent target for antibody development. The VP1 protein is a major immunodominant antigen, capable of eliciting a strong antibody response following infection or vaccination. Antibodies targeting this protein are essential for both diagnostic and research applications. For diagnostics, antibodies are utilized in immunoassays to detect the presence of the virus or a patient's immune response to it. A new ELISA has been shown to be effective for detecting IgG and IgA in serum following primary infection, highlighting the utility of specific antibodies in serological studies. Furthermore, recent research has successfully isolated and characterized broadly neutralizing antibodies that target conserved regions of the VP1 protein, providing a pathway for the development of broadly protective vaccines and therapeutic antibodies. These neutralizing antibodies can block the virus from binding to its receptors on host cells, effectively preventing infection.
At Creative Biolabs, our catalog includes a range of monoclonal and polyclonal antibodies that target the VP1 protein, validated for a variety of applications including ELISA, Western Blotting, and Immunohistochemistry, ensuring reliable results for your project.
Why Choose Us?
Our commitment to scientific excellence and customer success sets us apart. We leverage decades of experience and innovative platforms to provide antibody products that meet the highest standards of quality and performance.
- Exceptional Specificity: Our antibodies are rigorously tested for minimal cross-reactivity with structurally similar compounds, ensuring highly accurate results and reducing the likelihood of false positives.
- High Sensitivity: Products are developed and optimized for exceptional sensitivity, enabling the detection of even trace amounts of MDMA, which is critical for demanding research.
- Customization: We specialize in developing custom antibodies with defined attributes—like specific host species, isotype, or affinity for rare MDMA metabolites—to match your exact project requirements.
- Proven Performance: Published data and success stories demonstrate the reliability and effectiveness of our products in supporting critical research and diagnostic applications.
Creative Biolabs is your trusted partner for premium Norovirus Specific Antibody Products, providing the high-quality reagents and expert support you need to advance your research and diagnostic projects. Our commitment to quality, innovation, and customer success ensures you have the tools necessary to tackle the challenges of norovirus research and public health.
Access the Creative Biolabs Edge – Request Your Quote Now
FAQs
Q: Are these antibodies suitable for detecting multiple norovirus genotypes?
A: Our portfolio includes antibodies with varying specificities, ranging from those that target specific genotypes to those that can recognize a broader range of norovirus variants. We recommend consulting the product specifications to select the antibody that best suits your research or diagnostic needs.
Q: Can these antibodies be used for viral quantification?
A: Yes, our antibodies are validated for use in quantitative immunoassays like ELISA. By pairing them with appropriate standards, you can accurately and reliably quantify the amount of viral protein in your samples.
Q: What is the recommended sample type for using these antibodies?
A: The appropriate sample type depends on your specific application. For environmental detection, you might use food or water extracts. For clinical research, stool samples, serum, or cell lysates are common. Our antibodies are validated for use across a variety of complex matrices.
Q: Do you offer recombinant or custom-developed antibodies?
A: We specialize in producing recombinant antibodies and can develop custom solutions tailored to your unique research requirements, such as an antibody with a specific host species, isotype, or affinity.
Q: How do these antibodies assist in the development of therapeutic interventions?
A: Antibodies that can neutralize the virus by blocking its interaction with host cells are critical tools in the early stages of therapeutic development. They can be used to screen potential drug candidates and understand the mechanisms of viral neutralization.
